Nanotherapeutics Appoints Prasad Raje, Ph.D. as President and Chief Executive Officer

ALACHUA, Fla.–(BUSINESS WIRE)–Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that Prasad Raje, Ph.D., has been appointed President and Chief Executive Officer, succeeding James M. Matthew, who served as interim President and Chief Executive Officer and will retain his position as Chief Financial Officer.

Read the Full Article at BUSINESSWIRE

2017-11-29T22:58:40+00:00
Skip to toolbar